Date published: 2026-1-11

1-800-457-3801

SCBT Portrait Logo
Seach Input

EF-CAB8 Inhibitors

EF-CAB8 Inhibitors are a class of chemical compounds designed to selectively inhibit the EF-CAB8 protein, a component involved in calcium-binding and signaling pathways. EF-CAB8 is part of the larger EF-hand calcium-binding protein family, which is characterized by a helix-loop-helix structural motif that binds calcium ions. These proteins play crucial roles in various cellular processes, including muscle contraction, cell division, and signal transduction. By binding calcium, EF-CAB8 can alter its conformation, leading to changes in its interaction with other proteins and influencing downstream signaling events. Inhibitors targeting EF-CAB8 are essential tools in research, providing insights into the specific roles of calcium-binding proteins in cellular functions. Research utilizing EF-CAB8 Inhibitors focuses on understanding how calcium signaling is regulated within the cell and how alterations in EF-CAB8 activity affect broader physiological processes. By inhibiting EF-CAB8, researchers can disrupt normal calcium-binding activities, leading to changes in the cellular signaling pathways that rely on these interactions. This can help elucidate the specific functions of EF-CAB8 in various biological contexts, such as its role in maintaining calcium homeostasis or its involvement in specific signaling cascades. Additionally, EF-CAB8 Inhibitors allow scientists to study the evolutionary conservation of calcium-binding proteins across different species, providing a broader understanding of how these proteins have adapted to perform essential functions in diverse biological systems. Overall, EF-CAB8 Inhibitors are valuable tools for probing the complexities of calcium signaling and its impact on cellular physiology.

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Verapamil

52-53-9sc-507373
1 g
$374.00
(0)

A calcium channel blocker that inhibits L-type calcium channels, reducing calcium influx into cells, potentially affecting EF-hand domain protein function.

Nifedipine

21829-25-4sc-3589
sc-3589A
1 g
5 g
$59.00
$173.00
15
(1)

Another L-type calcium channel blocker, it decreases intracellular calcium levels, indirectly influencing EF-hand domain-containing proteins.

Dantrolene

7261-97-4sc-500165
25 mg
$350.00
7
(0)

Ryanodine receptor antagonist that inhibits calcium release from the sarcoplasmic reticulum, affecting calcium-dependent processes.

Thapsigargin

67526-95-8sc-24017
sc-24017A
1 mg
5 mg
$136.00
$446.00
114
(2)

A SERCA pump inhibitor, it leads to increased cytosolic calcium levels, indirectly impacting proteins with EF-hand domains.

2-APB

524-95-8sc-201487
sc-201487A
20 mg
100 mg
$28.00
$53.00
37
(1)

An IP3 receptor inhibitor, it modulates calcium release from intracellular stores, affecting calcium-mediated signaling.

Ryanodine

15662-33-6sc-201523
sc-201523A
1 mg
5 mg
$223.00
$799.00
19
(2)

A selective ryanodine receptor modulator, it alters calcium release from sarcoplasmic and endoplasmic reticulum.

Carbetocin

37025-55-1sc-504618
10 mg
$330.00
(0)

An inhibitor of intracellular calcium release, it modulates calcium signaling pathways.

Bepridil

64706-54-3sc-507400
100 mg
$1620.00
(0)

A calcium channel blocker with effects on both L-type and T-type channels, altering calcium dynamics.

Amlodipine

88150-42-9sc-200195
sc-200195A
100 mg
1 g
$74.00
$166.00
2
(1)

A long-acting calcium channel blocker, primarily affecting L-type channels and calcium homeostasis.

Nimodipine

66085-59-4sc-201464
sc-201464A
100 mg
1 g
$61.00
$307.00
2
(1)

A calcium channel blocker with specificity for cerebral arteries, influencing calcium signaling in the brain.